Vericel Q2 swings to GAAP profit of $2.2 million; revenue rises 22% to $77.5 million

Reuters2026/07/30 11:55

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Vericel Q2 revenue rose 22% to $77.5 million; net income turned to $2.2 million, or $0.04 per diluted share.
MACI revenue increased 23% to $65.5 million; Burn Care revenue climbed 22% to $12 million.
Gross margin was 73%; non-GAAP adjusted EBITDA margin was 19%.
Board authorized a $200 million share repurchase program; CEO Nick Colangelo cited strong first-half performance and a strong balance sheet.
Raised 2026 revenue guidance to $330 million-$340 million; reaffirmed gross margin near 75% and non-GAAP adjusted EBITDA margin near 27%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vericel Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607300755PRIMZONEFULLFEED9800569) on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Vericel Q2 swings to GAAP profit of $2.2 million; revenue rises 22% to $77.5 million

You may also like

Crypto prices